BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28948701)

  • 1. Hepatobiliary and Pancreatic: Hepatic necrobiotic xanthogranuloma.
    Nguyen BD
    J Gastroenterol Hepatol; 2017 Oct; 32(10):1667. PubMed ID: 28948701
    [No Abstract]   [Full Text] [Related]  

  • 2. Necrobiotic Xanthogranuloma on 18F-FDG PET/CT.
    Eltilib M; Fenner J; Saramago I; Oldan J
    Clin Nucl Med; 2020 Dec; 45(12):967-969. PubMed ID: 32969908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Slow increase of bilirubin concentration during administration of lenalidomide, bortezomib and dexamethasone for multiple myeloma (unmasking previously undiagnosed Gilbert syndrome) and disappearance of necrobiotic xanthogranuloma after complete remission of multiple myeloma.
    Adam Z; Řehák Z; Adamová Z; Pour L; Dvořáková K; Packová B; Koukalová R; Krejčí M; Krejčí M; Štork M; Sandecká V; Boichuk I; Král Z
    Klin Onkol; 2022; 35(4):315-322. PubMed ID: 35989089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete response to thalidomide and dexamethasone in a patient with necrobiotic xanthogranuloma associated with monoclonal gammopathy: a case report and review of the literature.
    Efebera Y; Blanchard E; Allam C; Han A; Lee S; Munshi N
    Clin Lymphoma Myeloma Leuk; 2011 Jun; 11(3):298-302. PubMed ID: 21658660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Necrobiotic xanthogranuloma associated with monoclonal gammopathy: successful treatment with lenalidomide and dexamethasone.
    Dholaria BR; Cappel M; Roy V
    Ann Hematol; 2016 Mar; 95(4):671-2. PubMed ID: 26814914
    [No Abstract]   [Full Text] [Related]  

  • 6. Necrobiotic xanthogranuloma.
    Jaén-Águila F; Vargas-Hitos JA; Jiménez-Alonso J
    QJM; 2014 Oct; 107(10):859. PubMed ID: 24659748
    [No Abstract]   [Full Text] [Related]  

  • 7. 18F-FDG PET/CT and MRI of necrobiotic xanthogranuloma.
    Nguyen BD
    Clin Nucl Med; 2014 Jan; 39(1):e101-3. PubMed ID: 23877513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Necrobiotic xanthogranuloma associated with smoldering multiple myeloma: satisfactory response to cyclophosphamide, dexamethasone, and thalidomide.
    Mello RB; Vale ECSD
    An Bras Dermatol; 2019 Jul; 94(3):337-340. PubMed ID: 31365665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Necrobiotic xanthogranuloma: response to chlorambucil.
    Ryan E; Warren LJ; Szabo F
    Australas J Dermatol; 2012 May; 53(2):e23-5. PubMed ID: 22571578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Necrobiotic xanthogranuloma as an unusual cause of refractive chronic bilateral leg ulceration.
    Ghiasi N; Alavi A; Coutts PM; Ghazarian D; Sibbald RG
    Int J Low Extrem Wounds; 2012 Dec; 11(4):293-5. PubMed ID: 23222162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Necrobiotic xanthogranuloma treated with lenalidomide.
    Mahendran P; Wee J; Chong H; Natkunarajah J
    Clin Exp Dermatol; 2018 Apr; 43(3):345-347. PubMed ID: 29048134
    [No Abstract]   [Full Text] [Related]  

  • 12. Necrobiotic Xanthogranuloma Treated With Topical Nitrogen Mustard (Mechlorethamine).
    Rodriguez O; Meyers C; Weiss BM; Elenitsas R; Rosenbach M
    JAMA Dermatol; 2016 May; 152(5):589-90. PubMed ID: 26762214
    [No Abstract]   [Full Text] [Related]  

  • 13. Complete remission of necrobiotic xanthogranuloma after disappearance of monoclonal immunoglobulin induced by bortezomib, lenalidomid and dexamethasone.
    Adam Z; Pour L; Řehák Z; Dvořáková K; Koukalová R; Feit J; Kameník P; Krejčí M; Štork M; Krejčí M; Sandecká V; Boichuk I; Král Z
    Vnitr Lek; 2021; 67(6):352-356. PubMed ID: 35459378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Necrobiotic xanthogranuloma treated with a combination of oral methylprednisolone and cyclosporin.
    Lee HJ; Kim JM; Kim GW; Kim HS; Kim BS; Kim MB; Ko HC
    J Dermatol; 2017 Oct; 44(10):1190-1191. PubMed ID: 27790743
    [No Abstract]   [Full Text] [Related]  

  • 15. Application of
    Hou J; Long T; Hu S
    Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):321-322. PubMed ID: 32409893
    [No Abstract]   [Full Text] [Related]  

  • 16. A patient with necrobiotic xanthogranuloma presenting with an anterior mediastinal mass, plasma cell dyscrasia, and a lymphoproliferative disorder.
    Chen KY; Leslie W; Mahon B; Venugopal P
    Clin Adv Hematol Oncol; 2011 Sep; 9(9):696-700. PubMed ID: 22402515
    [No Abstract]   [Full Text] [Related]  

  • 17. Periorbital necrobiotic xanthogranuloma treated successfully with novel multiple myeloma therapy.
    Ghani S; Al Ustwani O; Khalid B; Bogner P; Grassi M; Powell J; Bhat SA
    Clin Adv Hematol Oncol; 2013 Oct; 11(10):678-80. PubMed ID: 24518382
    [No Abstract]   [Full Text] [Related]  

  • 18. Necrobiotic Xanthogranuloma.
    Portuguese AJ; Long TH; Linenberger M
    Mayo Clin Proc; 2021 Sep; 96(9):2432-2434. PubMed ID: 34481598
    [No Abstract]   [Full Text] [Related]  

  • 19. Necrobiotic xanthogranuloma of the extremities with paraproteinemia and without periorbital involvement at presentation.
    Hashemi P; Rashidi A; Chapas AM; Balfour EM
    Cutis; 2012 Jan; 89(1):41-4. PubMed ID: 22439311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [
    Férnandez-Férnandez J; Rashki M; Rudolphi-Solero T; Rivas-Navas D; Ramos-Font C
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2022; 41 Suppl 1():S55-S56. PubMed ID: 35305945
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.